Loading...
Derniers dépôts
-
-
Anthony Turpin, Thierry de Baere, Alexandra Heurgué, Karine Le Malicot, Isabelle Ollivier-Hourmand, et al.. Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study. Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (2), pp.101464. ⟨10.1016/j.clinre.2020.05.012⟩. ⟨hal-04548045⟩
-
Emeric Boisteau, Eric François, Thomas Aparicio, Karine Le Malicot, Rabia Boulahssass, et al.. SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer. Digestive and Liver Disease, 2022, 54 (6), pp.747-754. ⟨10.1016/j.dld.2022.03.001⟩. ⟨hal-03632563⟩
-
-
-
Lyria Amari, Pascale Tomasini, Emmanuelle Dantony, Gaëlle Rousseau-Bussac, Charles Ricordel, et al.. Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study). Lung Cancer, 2024, 193, pp.107843. ⟨10.1016/j.lungcan.2024.107843⟩. ⟨hal-04652518⟩
-
Ester Gonzalez-Sanchez, Javier Vaquero, Daniel Caballero-Diaz, Jan Grzelak, Noel P. Fuste, et al.. The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche. Journal of Pathology, 2024, 263 (4-5), pp.482-495. ⟨10.1002/path.6299⟩. ⟨hal-04652471⟩
-
-
-
Ulrich Jarry, Mégane Bostoën, Jérôme Archambeau, Raphaël Pineau, Laura Chaillot, et al.. Afatinib or Bevacizumab in combination with Osimertinib efficiently control tumor development in orthotopic murine models of non-small lung cancer. PLoS ONE, 2024, 19 (6), pp.e0304914. ⟨10.1371/journal.pone.0304914⟩. ⟨hal-04650264⟩
-
Gael S. Roth, Loic Verlingue, Matthieu Sarabi, Jean Frédéric Blanc, Emmanuel Boleslawski, et al.. Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT). European Journal of Cancer, 2024, 202, pp.114000. ⟨10.1016/j.ejca.2024.114000⟩. ⟨hal-04626861⟩
-
Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, Richard Finn, Junji Furuse, et al.. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 2023, 401 (10391), pp.1853-1865. ⟨10.1016/S0140-6736(23)00727-4⟩. ⟨hal-04089083⟩
-
Louis-Marie Terrier, Luc Bauchet, Valérie Rigau, Aymeric Amelot, Sonia Zouaoui, et al.. Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database. Neuro-Oncology, 2017, 19 (5), pp.678-688. ⟨10.1093/neuonc/now186⟩. ⟨hal-02051153⟩
-
Coline Montégut, Jean-Sébastien Guillamo, François Ducray, Caroline Dehais, Cohen-Jonathan Moyal Elisabeth, et al.. Predictive geriatric factors in elderly patients treated for idh-mutant high-grade gliomas: a French Pola network study. Neuro-Oncology, 2021, 23 (6), pp.153. ⟨10.1093/neuonc/noab196.600⟩. ⟨hal-03600574⟩
-
Jeremie Naffrichoux, Pierre Poupin, William Pouillot, Claude Linassier, Nathalie Rioux-Leclercq, et al.. PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort. European Journal of Cancer, 2024, 205, pp.114121. ⟨10.1016/j.ejca.2024.114121⟩. ⟨hal-04615732⟩
-
Elena Cutrì, Ewan Morel--Corlu, Yan Rolland, Hervé Saint-Jalmes, Pierre-Antoine Eliat, et al.. A microscopic model of the dose distribution in hepatocellular carcinoma after selective internal radiation therapy. Physica Medica European Journal of Medical Physics, 2024, 122, pp.103384. ⟨10.1016/j.ejmp.2024.103384⟩. ⟨hal-04614632⟩
-
-
Quentin Dominique Thomas, Amal Boussere, Jean-Marc Classe, Christophe Pomel, Hélène Costaz, et al.. Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort. Gynecologic Oncology, 2022, 167 (1), pp.11-21. ⟨10.1016/j.ygyno.2022.08.005⟩. ⟨hal-03868125⟩
-
Déborah Iglicki, Myrtil L Kahn, Clément Goubault, Marielle Blot, Ulrich Jarry, et al.. Simple elaboration of drug-SPION nanocapsules (hybridosomes®) by solvent shifting: effect of the drug molecular structure and concentration. International Journal of Pharmaceutics, 2024, 649, pp.123645-123645. ⟨10.1016/j.ijpharm.2023.123645⟩. ⟨hal-04328696⟩
-
Alisée Meneu, Vincent Lavoué, Sophie Guillermet, Jean Leveque, Carole Mathelin, et al.. Comment l’activité physique pourrait-elle réduire le risque de survenue et de récidive des cancers du sein ?. Gynécologie Obstétrique Fertilité & Sénologie, 2024, 52 (3), pp.158-164. ⟨10.1016/j.gofs.2024.01.004⟩. ⟨hal-04577317⟩